<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>赛柏蓝 | wechat-feeds</title><link>http://MjM5NTA4Mzc2Mg.favicon.privacyhide.com/favicon.ico</link><description>赛柏蓝（Mic366）,中国医药行业专业的资讯信息分享互动平台，致力于及时、准确、有用！</description><managingEditor> (hellodword)</managingEditor><pubDate>Sat, 01 May 2021 21:29:21 +0800</pubDate><image><url>http://MjM5NTA4Mzc2Mg.favicon.privacyhide.com/favicon.ico</url><title>赛柏蓝 | wechat-feeds</title><link>http://MjM5NTA4Mzc2Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>知名药企，总经理离职</title><link>https://mp.weixin.qq.com/s/7LpG5SV41P03cNXZObLHYw</link><description></description><content:encoded><![CDATA[知名药企，总经理离职]]></content:encoded><pubDate>Sat, 01 May 2021 17:54:29 +0800</pubDate></item><item><title>二甲双胍，又发现多个新作用</title><link>https://mp.weixin.qq.com/s/0aWuukngAjalebSwLVcPQg</link><description></description><content:encoded><![CDATA[二甲双胍，又发现多个新作用]]></content:encoded><pubDate>Sat, 01 May 2021 17:54:29 +0800</pubDate></item><item><title>今起！第四批国采结果，这些省执行</title><link>https://mp.weixin.qq.com/s/dzB4eTttfuwVfUw-eHt-KA</link><description></description><content:encoded><![CDATA[今起！第四批国采结果，这些省执行]]></content:encoded><pubDate>Sat, 01 May 2021 17:54:29 +0800</pubDate></item><item><title>第五个适应症获批！恒瑞医药卡瑞利珠单抗再下一城</title><link>https://mp.weixin.qq.com/s/6ZzF77cVLsyxcWulMULeuw</link><description></description><content:encoded><![CDATA[第五个适应症获批！恒瑞医药卡瑞利珠单抗再下一城]]></content:encoded><pubDate>Sat, 01 May 2021 17:54:29 +0800</pubDate></item><item><title>国家药典委，发布160个中药配方颗粒标准</title><link>https://mp.weixin.qq.com/s/WkGfqbWKpTBCNa99pAvvdg</link><description></description><content:encoded><![CDATA[国家药典委，发布160个中药配方颗粒标准]]></content:encoded><pubDate>Sat, 01 May 2021 17:54:29 +0800</pubDate></item><item><title>药械营销迎来大变革</title><link>https://mp.weixin.qq.com/s/r0fBXIMpuYxGJw0PHu1Nbw</link><description></description><content:encoded><![CDATA[药械营销迎来大变革]]></content:encoded><pubDate>Sat, 01 May 2021 17:54:29 +0800</pubDate></item><item><title>药企新品上市， 市场部策划攻略</title><link>https://mp.weixin.qq.com/s/40d2L3VRvkdSPASp4V4OwA</link><description></description><content:encoded><![CDATA[药企新品上市， 市场部策划攻略]]></content:encoded><pubDate>Sat, 01 May 2021 17:54:29 +0800</pubDate></item><item><title>药企两大痛点，阿斯利康公开解决方案</title><link>https://mp.weixin.qq.com/s/DWkCQaldnffCT9AQa9tv1g</link><description></description><content:encoded><![CDATA[药企两大痛点，阿斯利康公开解决方案]]></content:encoded><pubDate>Sat, 01 May 2021 17:54:29 +0800</pubDate></item><item><title>刚刚！国家医保局公布国谈药品最新消息</title><link>https://mp.weixin.qq.com/s/ci6EK86OSOx_5KGky7QRIg</link><description></description><content:encoded><![CDATA[刚刚！国家医保局公布国谈药品最新消息]]></content:encoded><pubDate>Fri, 30 Apr 2021 16:50:14 +0800</pubDate></item><item><title>知名药企，裁撤整个部门</title><link>https://mp.weixin.qq.com/s/vcHeKcJUO2xX-IJreLj_1Q</link><description></description><content:encoded><![CDATA[知名药企，裁撤整个部门]]></content:encoded><pubDate>Fri, 30 Apr 2021 16:50:14 +0800</pubDate></item><item><title>奥司他韦竞品，正式上市</title><link>https://mp.weixin.qq.com/s/Ncyh031CEcZoUUy64Mxz7Q</link><description></description><content:encoded><![CDATA[奥司他韦竞品，正式上市]]></content:encoded><pubDate>Fri, 30 Apr 2021 16:50:14 +0800</pubDate></item><item><title>9个大品种，新一轮带量采购来了（附名单）</title><link>https://mp.weixin.qq.com/s/WcVpqtnJbmv2neqkGGA6fQ</link><description></description><content:encoded><![CDATA[9个大品种，新一轮带量采购来了（附名单）]]></content:encoded><pubDate>Fri, 30 Apr 2021 16:50:14 +0800</pubDate></item><item><title>医药数字化营销，未来趋势披露</title><link>https://mp.weixin.qq.com/s/WqZhbGIZuNvxcbO-cGdCSg</link><description></description><content:encoded><![CDATA[医药数字化营销，未来趋势披露]]></content:encoded><pubDate>Fri, 30 Apr 2021 16:50:14 +0800</pubDate></item><item><title>新形势下，药企如何做好代理商工作</title><link>https://mp.weixin.qq.com/s/brKnjvMuon9_fNJFkZi70g</link><description></description><content:encoded><![CDATA[新形势下，药企如何做好代理商工作]]></content:encoded><pubDate>Fri, 30 Apr 2021 16:50:14 +0800</pubDate></item><item><title>九州通，1100亿！3大业绩太震撼</title><link>https://mp.weixin.qq.com/s/ZQ2MCs4MbVxm2hQPG27kUg</link><description></description><content:encoded><![CDATA[九州通，1100亿！3大业绩太震撼]]></content:encoded><pubDate>Fri, 30 Apr 2021 16:50:14 +0800</pubDate></item><item><title>广东近百家药企虚开发票被罚</title><link>https://mp.weixin.qq.com/s/GTGkMB7zSGq_jXFzCN38_A</link><description></description><content:encoded><![CDATA[广东近百家药企虚开发票被罚]]></content:encoded><pubDate>Fri, 30 Apr 2021 16:50:14 +0800</pubDate></item><item><title>最新！53个大品种，11省带量采购开始（附名单）</title><link>https://mp.weixin.qq.com/s/yprPNaugg6sPJmRRiqtwTg</link><description></description><content:encoded><![CDATA[最新！53个大品种，11省带量采购开始（附名单）]]></content:encoded><pubDate>Thu, 29 Apr 2021 19:24:43 +0800</pubDate></item><item><title>两大中药榜单发布：血必净、连花清瘟、金花清感...</title><link>https://mp.weixin.qq.com/s/Ftd8DJxLo82FgZQrZieP9g</link><description></description><content:encoded><![CDATA[两大中药榜单发布：血必净、连花清瘟、金花清感...]]></content:encoded><pubDate>Thu, 29 Apr 2021 19:24:43 +0800</pubDate></item><item><title>九州通年报：营收超1108亿</title><link>https://mp.weixin.qq.com/s/1poSnFIIWDqIVJmcQTL9Gg</link><description></description><content:encoded><![CDATA[九州通年报：营收超1108亿]]></content:encoded><pubDate>Thu, 29 Apr 2021 19:24:43 +0800</pubDate></item><item><title>83所医药类大学，排名公布</title><link>https://mp.weixin.qq.com/s/nIGp3qbWcjkprpPcif-TYQ</link><description></description><content:encoded><![CDATA[83所医药类大学，排名公布]]></content:encoded><pubDate>Thu, 29 Apr 2021 19:24:43 +0800</pubDate></item></channel></rss>